Patricia Magness, NP
Gerontology · Fort Worth, TXNPI 1124537212
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,786 of the $5,021 with a category attached, or 75.4%. 29 manufacturers reported payments, led by Axonics, Inc. at 26.7% of the total. Reporting peaked in 2024 at $2,388 and has fallen 54.4% since, to $1,090 in 2025. Among gerontology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 84 payments — averaging $59.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$1K
- Medtronic$567
- Sumitomo Pharma America, Inc.$362
- Endo USA, Inc.$213
- Procept Biorobotics Corporation$208
- Boston Scientific$192
- plus $2K from 23 others
What the payments were for
- Travel & lodging$1,20824%
- Food & beverage$3,78675%
- Education$271%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 12 | $1,340 |
| Medtronic | 11 | $567 |
| Sumitomo Pharma America, Inc. | 9 | $362 |
| Endo USA, Inc. | 5 | $213 |
| Procept Biorobotics Corporation | 2 | $208 |
| Boston Scientific | 3 | $192 |
| Johnson & Johnson | 2 | $176 |
| Convatec Inc. | 1 | $169 |
| Astellas Pharma US Inc | 2 | $157 |
| Bayer | 2 | $151 |
| Antares Pharma, Inc. | 4 | $150 |
| Edwards Lifesciences | 1 | $142 |
| Teleflex LLC | 1 | $137 |
| Ferring Pharmaceuticals Inc. | 1 | $133 |
| Olympus America Inc. | 4 | $118 |
| Avation Medical, Inc. | 1 | $118 |
| Merck | 2 | $116 |
| Telix Pharmaceuticals | 2 | $112 |
| Myovant Sciences Inc. | 1 | $87 |
| Urogen Pharma, Inc. | 3 | $77 |
| Dendreon Pharmaceuticals LLC | 2 | $69 |
| Tolmar, Inc. | 4 | $57 |
| Novo Nordisk | 1 | $40 |
| Myriad Genetic Laboratories, Inc. | 2 | $37 |
| AbbVie | 2 | $31 |
| Endo Pharmaceuticals Inc. | 1 | $20 |
| Novartis | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Kerecis Limited | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics$1,071
- INTERSTIM$347
- GEMTESA$228
- Cure Catheter$169
- GENTLECATH$169
- AMS 700$147
- HemoSphere$142
- UroLift$137
- ADSTILADRIN$133
- AquaBeam Robotic System$127
- XIAFLEX$126
- Nubeqa$124
- Xofigo$124
- Erleada$119
- AKEEGA$119
- Veozah$118
- Vivally$118
- XYOSTED$113
How this compares
$5,021 in reported general payments places this provider in the 90th percentile of 653 gerontology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 130 | $77,609 |
| GemtesaVibegron | 77 | $64,260 |
| Estradiol | 44 | $3,157 |
| Trospium Chloride ErTrospium Chloride | 14 | $2,780 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 102 | $1,483 |
| Tamsulosin Hcl | 118 | $1,350 |
| Trospium Chloride | 30 | $1,088 |
| Methenamine Hippurate | 17 | $1,070 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 40 | $824 |
| Trimethoprim | 12 | $813 |
| Solifenacin Succinate | 12 | $446 |
| Finasteride | 35 | $326 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 47 | $313 |
| Testosterone Cypionate | 13 | $302 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 41 | $191 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $157 | $77,609130 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $362 | $64,26077 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 653 gerontology providers in Texas.
Other gerontology in Fort Worth
- Jennifer WestFort Worth$67K
- Kimberly PoseyFort Worth$4K
- Kimberly WelchCoppell$113K
- Tiffany KesslerDallas$84K
- Bailey EstesAbilene$34K
- Scott ZelaHouston$28K
- Marissa Marti-SmithDallas$27K
- Andrew BargerAustin$22K
- Meagan ChavarriaHouston$21K
- Samantha BoggsGalveston$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.